(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

What is it about?

Myasthenia gravis can be a source of significant psychosocial distress for patients, with symptoms such as insomnia and anxiety representing fairly common complaints. As these symptoms can negatively impact quality of life, effective treatment is particularly important, but can prove to be a challenge for providers given the unique pharmacologic constraints of the disease itself. This article provides an overview of available medication options through the lens of myasthenia gravis in an attempt to help guide providers in selecting safe and appropriate treatment for insomnia and anxiety in this patient population.

Read more on Kudos…
The following have contributed to this page:
Holly Jordan
' ,"url"));